PAUL DEBES: Open Payments
NPI 1891175840 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 46 payments from 7 companies in 2025. Trend: 2023 $1,178 · 2024 $1,330 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 14 | $420 |
| Gilead Sciences, Inc. | 22 | $346 |
| ABBVIE INC. | 4 | $87 |
| Antares Pharma, Inc. | 3 | $63 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Indivior Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: APRETUDE, RUKOBIA, CABENUVA, DOVATO, MAVYRET, XYOSTED, Biktarvy, PIFELTRO.
Industry payments across PA — which companies pay providers there.
